Literature DB >> 19012970

Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen.

Fiorenzo Mignini1, Daniele Tomassoni, Enea Traini, Francesco Amenta.   

Abstract

The localization of dopamine stores and the expression and localization of vesicular monoamine transporter (VMAT) type-1 and 2 and of dopamine D1-like and D2-like receptor subtypes were investigated in rat thymus and spleen by immunohistochemical, immunochemical techniques and by RT-PCR. In the thymus dopamine immunoreactivity was developed in the cortico-medullary junction and in the medulla, but not in the thymic cortex. In the spleen, dopamine stores were found in reticular structures in the white pulp border and in the white pulp, but not in the red one. Both thymus and spleen expressed VMAT-1 and VMAT-2 immunoreactivity as well as dopamine D1, D2, D3, D4 and D5 receptor immunoreactivity. Immunohistochemistry revealed VMAT-1, VMAT-2 and dopamine D1, D2, D3, D4 and D5 receptor immunoreactivity primarily in the thymic cortical-medulla transitional zone and to a lesser extent in the medulla but not in the cortex. In the spleen, VMAT-1, VMAT-2 and dopamine D1, D2, D3, D4 and D5 receptor immunoreactivity was located primarily in the white pulp border and to a lesser extent in the white pulp. These findings indicate that both thymus and spleen express a dopaminergic system characterized by the presence of dopamine, vesicular monoamine transporters and the five subtypes of dopamine receptors. The presence of these dopaminergic markers suggests that dopamine likely originating from immune cells and/or from sympathetic neuroeffector plexus is released in the lymphoid microenvironment. Based on the microanatomical localization of dopaminergic markers investigated, a role of dopamine in maturation and selection of lymphocytes and activation of immune responses is suggested.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012970     DOI: 10.1016/j.jneuroim.2008.09.018

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  18 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

2.  The inhibition of dopamine synthesis in fetuses changes the pattern of T-lymphocyte maturation in the thymus of adult rats.

Authors:  N V Lifantseva; Ts O Koneeva; S N Voronova; L A Zakharova; V I Melnikova
Journal:  Dokl Biochem Biophys       Date:  2016-11-06       Impact factor: 0.788

Review 3.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

4.  Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of 11C-(+)-PHNO.

Authors:  Jason Bini; Mika Naganawa; Nabeel Nabulsi; Yiyun Huang; Jim Ropchan; Keunpoong Lim; Soheila Najafzadeh; Kevan C Herold; Gary W Cline; Richard E Carson
Journal:  J Nucl Med       Date:  2018-01-25       Impact factor: 10.057

Review 5.  Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines.

Authors:  Chandrani Sarkar; Debanjan Chakroborty; Sujit Basu
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-11       Impact factor: 4.147

Review 6.  The immunoregulatory role of dopamine: an update.

Authors:  Chandrani Sarkar; Biswarup Basu; Debanjan Chakroborty; Partha Sarthi Dasgupta; Sujit Basu
Journal:  Brain Behav Immun       Date:  2009-11-05       Impact factor: 7.217

7.  Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.

Authors:  Wei Zhao; Yan Huang; Zhan Liu; Bei-Bei Cao; Yu-Ping Peng; Yi-Hua Qiu
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

8.  Intrinsic innervation and dopaminergic markers after experimental denervation in rat thymus.

Authors:  F Mignini; M Sabbatini; V D'Andrea; C Cavallotti
Journal:  Eur J Histochem       Date:  2010-04-15       Impact factor: 3.188

9.  PET Imaging of Pancreatic Dopamine D2 and D3 Receptor Density with 11C-(+)-PHNO in Type 1 Diabetes.

Authors:  Jason Bini; Elizabeth Sanchez-Rangel; Jean-Dominique Gallezot; Mika Naganawa; Nabeel Nabulsi; Keunpoong Lim; Soheila Najafzadeh; Anupama Shirali; Jim Ropchan; David Matuskey; Yiyun Huang; Kevan C Herold; Paul E Harris; Robert S Sherwin; Richard E Carson; Gary W Cline
Journal:  J Nucl Med       Date:  2019-10-10       Impact factor: 11.082

10.  Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse.

Authors:  Peter J Gaskill; Loreto Carvallo; Eliseo A Eugenin; Joan W Berman
Journal:  J Neuroinflammation       Date:  2012-08-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.